Remandish Pharma

Pharmaceutical products manufacturing, distribution, and innovation in India.

About Remandish Pharma

Remandish Pharma is a Healthcare company. Pharmaceutical products manufacturing, distribution, and innovation in India. Its Indian entity Remandish Pharma Private Limited reported revenue of β‚Ή34.7 Lakh. Remandish Pharma offers products and services including Medicines and Generic Drugs. Its focus areas include Pharmaceuticals, Medicine Manufacturing, Generic Drug Development and Research and Development.

Company details

Remandish Pharma Private Limited is recognized as a pharmaceutical company that prioritizes customer satisfaction through the provision of high-quality medicines at affordable prices and timely delivery. Efforts are made by the company to enhance quality of life via GMP, WHO, and ISO compliant products, supported by a committed team and capable infrastructure. Operations were initiated in 2011 across four states in India, with expansion planned nationwide, emphasizing safety, trust, innovation, and financial discipline in product development and compliance.

  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Legal Name Remandish Pharma Private Limited
  • Date of Incorporation 22 Nov, 2011
  • Jurisdiction Dehradun, Uttarakhand, India
Key Metrics
  • Indian entity revenue
    ₹34.7 Lakh

    FY 2025 · -12% YoY

  • Indian entity net profit
    ₹21,856

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹55,784

    FY 2025 · 2% margin

Products & Services of Remandish Pharma

Remandish Pharma offers a comprehensive portfolio of products and services, including Medicines and Generic Drugs.

Medicines
Pharmaceutical Products

Medicines are manufactured and supplied by Remandish Pharma, ensuring they are affordable and compliant with industry standards for quality and safety.

Generic Drugs
Healthcare Services

Generic drugs are developed and distributed by Remandish Pharma to provide safe and affordable options that address various clinical requirements.

Board of directors of Remandish Pharma Private Limited (Remandish Pharma)

Remandish Pharma Private Limited is the primary company behind Remandish Pharma. The board of Remandish Pharma Private Limited currently have 2 directors; the longest-serving is Sharvan Kumar, appointed in 2011.

DirectorDesignationAppointedTenureEntity
Sharvan Kumar
DIN 02388872
Director22 Nov 201114 yrs 11 moRemandish Pharma Private Limited
Vandana Kulshrestha
DIN 03608692
Director22 Nov 201114 yrs 11 moRemandish Pharma Private Limited

Financials of Remandish Pharma

Figures of Remandish Pharma Private Limited, the primary company behind Remandish Pharma, for FY 2025. Revenue was ₹34.7 Lakh (-12% year on year). Net profit was ₹21,856 (1% margin). EBITDA was ₹55,784 (2% margin). Revenue has grown at a compounded annual rate of +18% over three years and +11% over five years.

  • ₹34.7 LakhRevenue · FY 2025 · -12% YoY
  • ₹21,856Net profit · 1% margin
  • ₹55,784EBITDA · 2% margin
  • ₹1 LakhPaid-up capital
  • +18%Revenue CAGR, 3 years
  • +11%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Remandish Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Remandish Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Remandish Pharma

The primary company behind Remandish Pharma, Remandish Pharma Private Limited, reported revenue of β‚Ή34.7 Lakh for FY 2025, down 12% year on year.

Remandish Pharma Private Limited is recognized as a pharmaceutical company that prioritizes customer satisfaction through the provision of high-quality medicines at affordable prices and timely delivery. Efforts are made by the company to enhance quality of life via GMP, WHO, and ISO compliant products, supported by a committed team and capable infrastructure. Operations were initiated in 2011 across four states in India, with expansion planned nationwide, emphasizing safety, trust, innovation, and financial discipline in product development and compliance.

Remandish Pharma offers Medicines and Generic Drugs.

Remandish Pharma operates through Remandish Pharma Private Limited.

The legal entities of Remandish Pharma currently have 2 directors, including Sharvan Kumar, Vandana Kulshrestha.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available